Authors
Loading...
Findings reveal that MAIT cell-driven immunosuppression impacts skin lesions in chronic inflammatory disease, suggesting a therapeutic target.
Crossland et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: